<SEC-DOCUMENT>0001193125-21-277852.txt : 20210921
<SEC-HEADER>0001193125-21-277852.hdr.sgml : 20210921
<ACCEPTANCE-DATETIME>20210921083351
ACCESSION NUMBER:		0001193125-21-277852
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210921
DATE AS OF CHANGE:		20210921

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QuantumScape Corp
		CENTRAL INDEX KEY:			0001811414
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				850796578
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251433
		FILM NUMBER:		211264886

	BUSINESS ADDRESS:	
		STREET 1:		1730 TECHNOLOGY DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110
		BUSINESS PHONE:		(408) 452-2000

	MAIL ADDRESS:	
		STREET 1:		1730 TECHNOLOGY DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kensington Capital Acquisition Corp.
		DATE OF NAME CHANGE:	20200505
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d214579d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(3) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-251433</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus dated
May&nbsp;18, 2021) </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>306,053,642 Shares of Class&nbsp;A Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6,650,000 Warrants </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g214579g0921111057267.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement supplements the prospectus dated May&nbsp;18, 2021 (as supplemented to date, the
&#147;Prospectus&#148;), which forms a part of our Registration Statement on Post-Effective Amendment No.&nbsp;3 to the Form <FONT STYLE="white-space:nowrap">S-1</FONT> (Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-</FONT>
251433) filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on May&nbsp;17, 2021 and declared effective by the Commission on May&nbsp;18, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus and this Prospectus Supplement relate to the disposition from time to time of 1) up to 306,053,642 shares of our Class&nbsp;A
Common Stock, which include Class&nbsp;A Common Stock issuable upon conversion of our Class&nbsp;B Common Stock, the exercise of certain private placement and public warrants (together, the &#147;Warrants&#148;), the exercise of certain stock
options, and the vesting of certain restricted stock units, and 2) up to 6,650,000 private placement warrants, which are held or may be held by the selling securityholders named in the Prospectus. We will not receive any proceeds from the sale of
our securities offered by the selling securityholders under the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;24, 2021, we redeemed all outstanding public
warrants that had not been exercised as of such date (the &#147;Redemption Date&#148;). We have received an aggregate of $151,430,588.87 from the cash exercise of public warrants prior to the Redemption Date, net of the amount paid for redemption of
unexercised public warrants. We expect to receive approximately $53,582,122.50 assuming the exercise of all outstanding private placement warrants for cash at a current exercise price of $11.50 per share, less the amount that will not be received
due to cashless exercises and redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement should be read in conjunction with the Prospectus, which is to be
delivered with this Prospectus Supplement. This Prospectus Supplement updates, amends and supplements the information included or incorporated by reference in the Prospectus. If there is any inconsistency between the information in the Prospectus
and this Prospectus Supplement, you should rely on the information in this Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement is not
complete without, and may not be delivered or utilized except in connection with, the Prospectus, including any amendments or supplements to it. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;21, 2021, we filed a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> with the Commission. The portion of
the text of such Form <FONT STYLE="white-space:nowrap">8-K</FONT> that is treated as &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended, is attached hereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in our securities involves a high degree of risk. In reviewing the Prospectus
and this Prospectus Supplement, you should carefully consider the matters described under the heading &#147;</B><B><I>Risk Factors</I></B><B>&#148; beginning on page 6 of the Prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained in the Prospectus, this Prospectus Supplement or any Prospectus Supplement or amendment
hereto. We have not authorized anyone to provide you with different information. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this prospectus supplement is September&nbsp;21, 2021. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section 13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of report (Date of earliest event reported): September 17, 2021 </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-39345</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>85-0796578</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1730 Technology Drive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>San Jose, California</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>95110</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(408) 452-2000 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:8pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Class A common stock, par value $0.0001 per share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>QS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The New York Stock Exchange</B></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (&#167;&nbsp;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&nbsp;240.12b-2). </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Events </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">QuantumScape Corporation (the &#147;Company&#148;) recently signed an agreement with a second top ten (by global revenues) automotive original equipment
manufacturer (&#147;OEM&#148;) in which the OEM committed to collaborate with the Company to evaluate prototypes of the Company&#146;s solid-state battery cells, and to purchase 10 MWh of capacity from the Company&#146;s <FONT
STYLE="white-space:nowrap">pre-pilot</FONT> production line facility <FONT STYLE="white-space:nowrap">(&#147;QS-0&#148;)</FONT> for inclusion in <FONT STYLE="white-space:nowrap">pre-series</FONT> vehicles, subject to satisfactory validation of
intermediate milestones. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The OEM has already evaluated early cells, and the intermediate milestones consist of more advanced prototypes of the
Company&#146;s cells, expected to be delivered before <FONT STYLE="white-space:nowrap">QS-0</FONT> starts production in 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking
Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain information in this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> may be considered &#147;forward-looking
statements,&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding the Company&#146;s
ability to satisfactorily meet the intermediate milestones agreed to with the OEM, future timeline, product development and production. These forward-looking statements are based on management&#146;s current expectations, assumptions, hopes,
beliefs, intentions and strategies regarding future events and are based on currently available information as to the outcome and timing of future events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected
results. Factors that may cause such differences include, but are not limited to ones listed here. The Company faces significant barriers in its attempts to produce a solid-state battery cell and may not be able to successfully develop its
solid-state battery cell. Building high volumes of multi-layer cells in commercially relevant sizes and with higher layer count requires substantial development effort. The Company could encounter significant delays and/or technical challenges in
replicating the performance seen in its single-layer cells and four-layer cells and in achieving the high quality, consistency, throughput and performance targets required for commercial production and sale. The Company may encounter delays and
other obstacles in acquiring, installing and operating new manufacturing equipment for automated and/or continuous-flow processes, including vendor delays (which we have already experienced) and challenges optimizing complex manufacturing processes.
The Company may encounter delays in hiring the engineers it needs to expand its development and production efforts, delays in planning, permitting, building out and commencing operations at <FONT STYLE="white-space:nowrap">QS-0,</FONT> and delays
caused by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Delays in increasing production of engineering samples would slow the Company&#146;s development efforts. The Company may be unable to adequately control the costs associated
with its operations and the components necessary to build its solid-state battery cells at competitive prices. The Company&#146;s spending may be higher than currently anticipated. The Company may not be successful in competing in the battery market
industry or establishing and maintaining confidence in its long-term business prospectus among current and future partners and customers. The Company may be adversely impacted by litigation and regulatory proceedings. The Company cautions that the
foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Further information about factors that could materially affect the
Company, including its results of operations and financial condition, is set forth under the &#147;Risk Factors&#148; section in the quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed by the Company with the SEC on
July&nbsp;29, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements. Should
underlying assumptions prove incorrect, actual results and projections could differ materially from those expressed in any forward-looking statements. Additional information concerning these and other factors that could materially affect the
Company&#146;s actual results can be found in the Company&#146;s periodic filings with the SEC. The Company&#146;s SEC filings are available publicly on the SEC&#146;s website at <U>www.sec.gov</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: September&nbsp;21, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>QUANTUMSCAPE CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael McCarthy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael McCarthy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Legal Officer and Head of Corporate Development</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g214579g0921111057267.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g214579g0921111057267.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !R 0X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBD) !)
M. .I- "T5YWKGQ=TFUU!M*\/65UXCU4''DV"YC4_[3X(_(&L\2_&37B'CBT7
MP[ W19#YLH'O]X9_*@#U2BO*O^$$^)<_S7'Q*,;'J(K(8_3%'_"$?%"WYM_B
M.DA'::R7'Z@T >JT5Y48?C3I9RMUX?UA!_"R^6Q_1!^M-_X6CXLT3_D:/A]?
MQQK]ZXT]O-0?AR/_ !Z@#U>BN(T'XM^#/$#K%#JZ6MP3CR+T>2V?3)^4GZ&N
MV5@RAE(*D9!!X- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5Y/J%SJ?Q9UJZT?2[J6Q\'V4ABO;Z$X>^D'6-#_=
M'KT[\Y KJ?B5J-W8^#9K;3FVZAJ<T>G6S9QAY6VY_!=Q_"MSP_H=GX;T&STB
MQ0+;VL80<<L>['W)R3]: &Z#X;TCPQIRV.CV,5K HYV#YG/JS=6/N:U:** "
MBBB@ HHHH Y[7O WACQ*K#5M%M9Y&'^N";)!_P #7!_6N*/PS\2>$V,_@/Q1
M/'"O/]F:D?,A;V![?EGWKU:B@#S73OBJ^F7J:7X\T>7P_>L=J76"]K*?9QG'
MYD>IKT>&:*XA2:"5)8G&Y'1@RL/4$=:AO].LM5LI+/4+6&ZMI!AXID#*?P->
M>R>"-<\$S/?> KSS;(DO+H-[(3$_KY3GE#]?Q/:@#TNBN;\+>--.\4":W5);
M'5;;BZTZZ&R:$_3^)?\ :'Z5TE !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!RGC&'SM6\([AF--9#'ZB";'ZXKJZQ?$]H\^G07$
M4;2365W#=(J#)(5QN _X 6K:H **** "BBB@ HHHH **** "BBB@#G/$W@ZP
M\2&&Z$DECJUJ=UIJ5M\LL1]/]I?53P>:JZ#XFO8M27P[XHBCMM8P3;W$?$&H
M*.K1GLX_B0\CJ.*ZVL[6]$L?$&FM8W\99"0\<B-MDB<?==&'*L#R"* -&BN<
MT+4K^TO/[ UZ0/?HI:UO -JWT0_BQT$B\;E_$<'CHZ "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "O%?'GQMGM-9;P]X,M%O[\/Y3W.PR
M+O[K&H^\1Z]/8UW/Q2UV;P[\.-8O[9REP8Q#$XZJ78+D>X!)_"N)_9]\)6EG
MX8;Q--$KW][(\<4C#F.)3M('IE@<_04 <[_Q?QHO[0S< 9W>3_HP./39U_#K
M6UX)^-]T=97P_P".+,6-X7$8NO+,85^PD0_=SZCCV'6O;Z\@^/OA&TU+P@WB
M*.%5U#3F7=(!S)$S!2I]<$@CTY]: /7Z*\N\&>/)+?X&Q>([V)[N;38C#*F_
M#2;&"CDYYVE:ZCP#XTC\=^'6U>*Q>S5;AH/+>0.?E .<X'K0!U-%>?Z1\4(=
M6^)-YX-72I(I+9Y5-R9@0VS_ &<=_K1\0_BOI7@%X[1H'OM3E7>+9'"A%[%V
MYQGL,$T >@45XC9?M$V?V"Y;5- GM;V- \$0FRL_(!&XJ"IP2>A!Q7>:3X_B
MU7X:S^,UT]XXXH9I?LIE!)\LL,;L=]OI0!V5%>)2_M%V+Z0DMGH%Q+J+R,/L
MOG95$ 'S%@O?)X [=:Z?X<_%S3O'MS+I[V;V&I1IY@A:3>LBCJ5; Y&>A'Y\
MT ;OB?X@^'_"&HVECJ\\T<]VNZ(1PEP1G'4>]=37RI\9_%@UGQ_#'_9\L']C
MRO;DLV?/VR9W#C@''O7MO@+XF+XX75&&BSV'V"-'/FR;O,W;N!P,?=_6@#L-
M6TN'5K/R9&:.1&$D$Z??AD'1U]Q^H)!X)J:Q:Z:SC^VQHER!MD\LY5B.-P]C
MUP>1FN*^''Q.@^(<FHI#I<EE]B$9)>8/OW[O0#&-OZTS7OBC!H7Q%T_P@VE2
M327CPJ+D3 !?,;;]W'./K0!Z!17!?$'XG6_@"^TRVGTU[H7P8[Q,$$84@<\'
M/7]*XN[_ &C;.#5ML/AZYETG>56Z,NUY #RRKC'X9_*@#W&BO&?$?[0>EV%P
M(M TN75HU17EN&<Q(F1G'W2<CH<XY]:[SP'X[T[Q]HC7]E&\$T+^7<6TA!:-
MNHY[@]C]: /*?$'Q0\9>+?&-QX=\ Q>7% [)YR(I>0*<,Y9_E1<]/P]<4NC^
M-?B?X0\6V.C^*]/GU2&]?")'&CN1QDQNG!(ZD'].M<[:7FJ? _XE7\E[ISW6
MEWFY$D''FQ%MRLK=-P[@^_L:]V\)?$3PSXUXTJ\'VM5RUK.NR51WP.X]P30!
MU=%9'B7Q+I?A/19=5U:?RK:,A0 ,L['HJCN37C[_ +1K&8SP^$YVTU6VF9KC
M#?HNT'VS0![O17*ZGX_TC1_!%OXJOUN(+:XC5X;=TQ,[,,J@7/7OUQCFO-M/
M_:-@FOP;[PW/;Z8SA3<QS>8R>Y&T _0'\Z /<Z*X#P#\4;;Q[K&I6%MIKVRV
M:;Q,9@XD&[ P,#'K6+J?QWTG1O$>L:3?Z5<)_9S21K*DH8SNK !0N!C/7)/
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MV(ZCL<<5XUI?AWXN?#:2[TS0+5;VQGD+K)&J2(3TW@,<J< 9!XX[T 6/!O\
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M#P3$+W3[HD!!M8A"<A71B#D=B/TR16EX(^'/BW6O'T?C/QQB&2!Q+'"2N]W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
